We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 81-100 of 5,831 results

  1. The prognostic impact of lead times in colorectal cancer patients undergoing cytoreductive surgery and HIPEC

    Background

    National lead time goals have been implemented across Sweden to standardize and improve cancer patient care. However, the prognostic impact...

    Ylva Jansson, Wilhelm Graf, Lana Ghanipour in World Journal of Surgical Oncology
    Article Open access 19 September 2022

  2. Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)

    Stephanie N. Gregory, Carrie E. Ryan, ... Willemien J. van Driel in Annals of Surgical Oncology
    Article 29 December 2022

  5. Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment

    Background

    CRS-HIPEC provides oncologic benefit in well-selected patients with peritoneal carcinomatosis; however, it is a morbid procedure. Decision...

    Mohamed A. Adam, Helen Zhou, ... Haroon M. Choudry in Annals of Surgical Oncology
    Article 02 June 2023

  6. Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer with Peritoneal Dissemination (PERISCOPE II)

    Amber Leila Sarvestani, Stephanie N. Gregory, ... Johanna W. van Sandick in Annals of Surgical Oncology
    Article 10 November 2023

  8. Complete pathological response of colorectal peritoneal metastases in Lynch syndrome after immunotherapy case report: is a paradigm shift in cytoreductive surgery needed?

    Background

    We report the first case of a patient affected by peritoneal metastases from colon cancer, arising in the context of Lynch syndrome with...

    Marco Tonello, Floriana Nappo, ... Antonio Sommariva in BMC Gastroenterology
    Article Open access 10 January 2022

  9. Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial

    Background

    As part of a randomized phase II trial in patients with isolated resectable colorectal peritoneal metastases (CPMs), the present study...

    C. Bakkers, K. P. Rovers, ... M. Koopman in Annals of Surgical Oncology
    Article Open access 08 February 2023

  10. Long-Term Survival in Patients Treated by Cytoreductive Surgery with or Without HIPEC for Peritoneal Surface Malignancies—A report from the Indian HIPEC Registry

    A previous report from the Indian HIPEC registry showed acceptable early survival and morbidity in patients undergoing cytoreductive surgery...

    Snita Sinukumar, Praveen Kammar, ... Aditi Bhatt in Indian Journal of Surgical Oncology
    Article 09 March 2023

  11. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis

    Background

    Open cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with high morbidity, which limits the...

    Chae Yun Cho, Jula Veerapong, ... Kaitlyn J. Kelly in Surgical Endoscopy
    Article Open access 07 December 2022

  14. Prognostic significance of the immuno-peritoneal cancer index in peritoneal metastatic patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

    Purpose

    A valid comparison of immune function among different patients with different primary pathologies or even with different tumour burdens...

    Yasemin Yildirim, Selman Sokmen, ... Funda Obuz in Langenbeck's Archives of Surgery
    Article 06 May 2023

  16. Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative

    Introduction

    Patients with colorectal peritoneal metastases (CRPM) are increasingly treated with cytoreductive surgery and hyperthermic...

    Nadege T. Fackche, Ryan K. Schmocker, ... Jonathan B. Greer in Annals of Surgical Oncology
    Article 03 February 2024

  18. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: lessons from 20 years’ experience

    Objectives

    We report the 20-year experience of the largest Australian unit performing cytoreductive surgery (CRS) and hyperthermic intraperitoneal...

    R. Farrell, W. S. Liauw, D. L. Morris in BMC Surgery
    Article Open access 12 September 2022

  20. The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis

    Backgrounds

    At present, the application of tumor reduction surgery in oligometastatic prostate cancer has aroused extensive discussion among...

    Bisheng Cheng, Shuchao Ye, Peiming Bai in World Journal of Surgical Oncology
    Article Open access 29 May 2021
Did you find what you were looking for? Share feedback.